Amid Covid Booster Debate, West Virginia to Check Immunity of Vaccinated Nursing Home Residents
(By Phil Galewitz for Kaiser Health News) West Virginia raced ahead of the country last winter to get people in
Read More
Part D/Prescription Drugs
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
(By Julie Appleby for Kaiser Health News) The long list of side effects that follow ads for the newer expensive
Read MorePfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales
(By Jay Hancock for Kaiser Health News) Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations
Read MoreHow to make a informed decision before signing up for Medicare
If you are nearing your 65th birthday, you probably have been bombarded by telemarketers, direct mail advertisements, social media, banner
Read MoreHow drug pricing proposals would lower costs
A recent survey found 80 percent of American adults believe prescription drugs are unreasonably expensive, and almost 90 percent of
Read MoreBe sure to avoid costly mistakes with Medicare
If you are still working and turning 65 and have insurance through your job, you still need to know the
Read MoreFacing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
(By Julie Appleby for Kaiser Health News) Do you sometimes lose your train of thought or feel a bit more
Read MoreSeniors shopping for Medicare coverage
The American Association for Medicare Supplement Insurance (AAMSI) found in their latest survey more than half of the seniors currently
Read MoreAnalysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon
(By Elisabeth Rosenthal for Kaiser Health News) The drugmaker Pfizer recently announced that vaccinated people are likely to need a
Read MoreThe disconnection between Medicare’s financial outlook and Congress
James C. Capretta, Senior Fellow and Milton Friedman Chair, whose article appearing on AEI, asks: Expand Medicare? How about we
Read More